Unknown

Dataset Information

Short and long-term safety of the 2009 AS03-adjuvanted pandemic vaccine.


ABSTRACT:

Background

This study assessed the short and the long term safety of the 2009 AS03 adjuvanted monovalent pandemic vaccine through an active web-based electronic surveillance. We compared its safety profile to that of the seasonal trivalent inactivated influenza vaccine (TIV) for 2010-2011.

Methodology/principal findings

Health care workers (HCW) vaccinated in 2009 with the pandemic vaccine (Arepanrix ® from GSK) or HCW vaccinated in 2010 with the 2010-2011 TIV were invited to participate in a web-based active surveillance of vaccine safety. They completed two surveys the day-8 survey covered the first 7 days post-vaccination and the day-29 survey covered events occurring 8 to 28 days after vaccination. Those who reported a problem were called by a nurse to obtain details. Th

SUBMITTER: De Serres G 

PROVIDER: S-EPMC3389012 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature